Aquablation Sales Representative - Japan at PROCEPT BioRobotics

Japan

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Devices, Healthcare, MedTechIndustries

Requirements

Candidates should possess a Bachelor’s degree and demonstrate a strong sales background, with a preference for experience in medical device sales or similar high-technology industries. The ideal candidate will also exhibit excellent communication and interpersonal skills, as well as the ability to build strong relationships with key stakeholders.

Responsibilities

The Aquablation Sales Representative will be responsible for launching the Aquabeam Robotic System in the designated territory, establishing Aquablation as the preferred treatment for BPH, and maximizing the utilization of installed systems. This includes developing territory plans, providing sales forecasts, communicating the product’s value proposition, collaborating with hospital staff and surgeons, driving system adoption, delivering training, and expanding the user base through lead generation and account management, while partnering with the Professional Education team to provide clinical and training support to physicians.

Skills

Medical Sales

Territory Management

Sales Forecasting

Value Proposition Selling

Surgeon Training

Lead Generation

Product Launch

Solution Selling

Hospital Administration

Urology

PROCEPT BioRobotics

Develops robotic solutions for BPH treatment

About PROCEPT BioRobotics

PROCEPT BioRobotics develops robotic solutions specifically for treating benign prostatic hyperplasia (BPH), a condition that affects many older men by causing prostate enlargement and urinary issues. Their main product, the AquaBeam Robotic System, utilizes Aquablation therapy, which combines real-time imaging, robotics, and waterjet technology to precisely remove prostate tissue in a minimally invasive manner. This system is designed for urologists and healthcare facilities, focusing on enhancing patient outcomes and making surgical procedures more efficient. Unlike competitors, PROCEPT BioRobotics emphasizes predictable results and reduced complications, which has led to their technology being recognized in clinical guidelines. The company's goal is to improve the quality of life for patients suffering from BPH through advanced surgical solutions.

Redwood City, CaliforniaHeadquarters

2009Year Founded

$319.1MTotal Funding

IPOCompany Stage

Robotics & Automation, HealthcareIndustries

501-1,000Employees

Benefits

Health Insurance

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Parental Leave

Paid Holidays

Wellness Program

Gym Membership

Risks

Competition from Intuitive Surgical and Medtronic may impact market share.

$175 million public stock offering could lead to shareholder dilution.

Reliance on AquaBeam System makes company vulnerable to technological failures.

Differentiation

AquaBeam Robotic System offers image-guided, minimally invasive urologic surgery.

Aquablation therapy provides effective outcomes regardless of prostate size or surgeon experience.

PROCEPT has over 100 peer-reviewed publications supporting Aquablation therapy's benefits.

Upsides

Increasing adoption of robotic-assisted surgeries boosts demand for AquaBeam System.

Global urology devices market projected to grow at 6.9% CAGR until 2030.

FDA's supportive regulatory environment favors innovative medical technologies like PROCEPT's.

Land your dream remote job 3x faster with AI

Try Jobo Free